Renaissance Technologies
LOGC

Renaissance Technologies’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Renaissance Technologies’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$77K Sell
2022
Q2 		$147K Sell
2022
Q1 		$312K Buy
2021
Q4 		– Sell
2021
Q3 		$216K Sell
2021
Q2 		$428K Buy